| Summary of Revenue by Product |
A
summary of the Company’s revenue by product type for the nine months ended April 30, 2026 and 2025 is as follows:
Summary of Revenue by Product
| | |
2026 | | |
2025 | |
| | |
April 30, | |
| | |
2026 | | |
2025 | |
| PURE Hard Surface | |
$ | 1,550,000 | | |
$ | 1,242,000 | |
| SILVÉRION | |
| 106,000 | | |
| 193,000 | |
| Revenue | |
$ | 1,656,000 | | |
$ | 1,435,000 | |
A
summary of the Company’s revenue by product type for the three months ended April 30, 2026 and 2025 is as follows:
| | |
2026 | | |
2025 | |
| | |
April 30, | |
| | |
2026 | | |
2025 | |
| PURE Hard Surface | |
$ | 92,000 | | |
$ | 468,000 | |
| SILVÉRION | |
| 414,000 | | |
| 21,000 | |
| Revenue | |
$ | 506,000 | | |
$ | 489,000 | |
|
| Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Shares Outstanding |
Schedule of Anti-dilutive Securities Excluded from Computation of Diluted Shares Outstanding
| | |
2026 | | |
2025 | |
| | |
April 30, | |
| | |
2026 | | |
2025 | |
| Common stock options | |
| 13,395,000 | | |
| 10,060,000 | |
| Restricted stock units | |
| 712,500 | | |
| 742,500 | |
| Shares issuable upon the conversion of debt | |
| 57,763,172 | | |
| 39,452,645 | |
| Total | |
| 71,870,672 | | |
| 50,255,145 | |
|
| Schedule of Inventories |
Inventories
consist of the following:
Schedule of Inventories
| | |
April 30, 2026 | | |
July 31, 2025 | |
| Raw materials | |
$ | 12,000 | | |
$ | 14,000 | |
| Finished goods | |
| 220,000 | | |
| 127,000 | |
| Inventories | |
$ | 232,000 | | |
$ | 141,000 | |
|
| Schedule of Significant Segment Expenses and Other Segment Items |
Schedule of Significant Segment Expenses and Other Segment Items
For
the nine months ended April 30, 2026 and 2025.
| | |
2026 | | |
2025 | |
| | |
For the Nine Months Ended April 30, | |
| | |
2026 | | |
2025 | |
| Revenue | |
$ | 1,658,000 | | |
$ | 1,438,000 | |
| | |
| | | |
| | |
| Less: | |
| | | |
| | |
| Cost of goods sold | |
| (701,000 | ) | |
| (603,000 | ) |
| General and administrative | |
| (2,151,000 | ) | |
| (2,411,000 | ) |
| Research and development | |
| (239,000 | ) | |
| (243,000 | ) |
| Stock-based compensation | |
| (147,000 | ) | |
| (117,000 | ) |
| Interest expense, net | |
| (301,000 | ) | |
| (210,000 | ) |
| Other income | |
| 8,000 | | |
| 79,000 | |
| NET LOSS | |
$ | (1,873,000 | ) | |
$ | (2,067,000 | ) |
For
the three months ended April 30, 2026 and 2025.
| | |
2026 | | |
2025 | |
| | |
For the Three Months Ended April 30, | |
| | |
2026 | | |
2025 | |
| Revenue | |
$ | 506,000 | | |
$ | 491,000 | |
| | |
| | | |
| | |
| Less: | |
| | | |
| | |
| Cost of goods sold | |
| (237,000 | ) | |
| (208,000 | ) |
| General and administrative | |
| (653,000 | ) | |
| (743,000 | ) |
| Research and development | |
| (79,000 | ) | |
| (91,000 | ) |
| Stock-based compensation | |
| (55,000 | ) | |
| (33,000 | ) |
| Interest expense, net | |
| (106,000 | ) | |
| (78,000 | ) |
| Other income | |
| - | | |
| 82,000 | |
| NET LOSS | |
$ | (624,000 | ) | |
$ | (580,000 | ) |
|